Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Pathophysiology, diagnosis and management of postoperative dumping syndrome

Abstract

Dumping syndrome is a frequent complication of esophageal, gastric or bariatric surgery. Rapid gastric emptying, with the delivery to the small intestine of a significant proportion of solid food as large particles that are difficult to digest, is a key event in the pathogenesis of this syndrome. This occurrence causes a shift of fluid from the intravascular component to the intestinal lumen, which results in cardiovascular symptoms, release of several gastrointestinal and pancreatic hormones and late postprandial hypoglycemia. Early dumping symptoms comprise both gastrointestinal and vasomotor symptoms. Late dumping symptoms are the result of reactive hypoglycemia. Besides the assessment of clinical alertness and endoscopic or radiological imaging, a modified oral glucose tolerance test might help to establish a diagnosis. The first step in treating dumping syndrome is the introduction of dietary measures. Acarbose can be added to these measures for patients with hypoglycemia, whereas several studies advocate guar gum or pectin to slow gastric emptying. Somatostatin analogs are the most effective medical therapy for dumping syndrome, and a slow-release preparation is the treatment of choice. In patients with treatment-refractory dumping syndrome, surgical reintervention or continuous enteral feeding can be considered, but the outcomes of such approaches are variable.

Key Points

  • Dumping syndrome is a common complication of esophageal and gastric (including bariatric) surgery

  • Symptoms include early (gastrointestinal and vasomotor) and late (hypoglycemia) symptoms

  • Diagnosis is based on a suggestive symptom pattern in patients with the appropriate surgical history; a modified oral glucose tolerance test might help to establish the diagnosis

  • Initial therapy should focus on dietary measures; acarbose can be added to these measures in patients with hypoglycemia

  • In patients who have not responded to initial therapy, (slow-release) somatostatin analogs are the treatment of choice

  • In patients with treatment-refractory dumping syndrome, surgical reinterventions or continuous enteral feeding can be considered, but the outcomes of such approaches are variable

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Pathophysiology of dumping syndrome and mode of action of different therapeutic agents.
Figure 2: Proposed treatment algorithm for dumping syndrome.

Similar content being viewed by others

References

  1. Kindt, S. & Tack, J. Impaired gastric accommodation and its role in dyspepsia. Gut 55, 1685–1691 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tack, J. Gastric motor disorders. Best Pract. Res. Clin. Gastroenterol. 21, 633–644 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Bisschops, R. et al. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 57, 1495–1503 (2008).

    Article  CAS  PubMed  Google Scholar 

  4. Hertz, A. F. The cause and treatment of certain unfavorable after-effects of gastro-enterostomy. Proc. R. Soc. Med. 6, 155–163 (1913).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. MacGregor, I., Parent, J. & Meyer, J. H. Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man. Gastroenterology 72, 195–205 (1977).

    CAS  PubMed  Google Scholar 

  6. Mayer, E. A. et al. Gastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy. Gastroenterology 83, 184–192 (1982).

    CAS  PubMed  Google Scholar 

  7. Vecht, J., Masclee, A. & Lamers, C. The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment. Scand. J. Gastroenterol. 223, 21–27 (1997).

    CAS  Google Scholar 

  8. McLarty, A. et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann. Thorac. Surg. 63, 1568–1572 (1997).

    Article  CAS  PubMed  Google Scholar 

  9. Pimpalwar, A. & Najmaldin, A. Results of laparoscopic antireflux procedures in neurologically impaired children. Semin. Laparosc. Surg. 9, 190–196 (2002).

    Article  CAS  PubMed  Google Scholar 

  10. Zaloga, G. P. & Chernow, B. Postprandial hypoglycemia after Nissen fundoplication for reflux esopahgitis. Gastroenterology 84, 840–842 (1983).

    Article  CAS  PubMed  Google Scholar 

  11. Abell, T. L. & Minocha, A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am. J. Med. Sci. 331, 214–218 (2006).

    Article  PubMed  Google Scholar 

  12. Sigstad, H. A clinical diagnostic index in the diagnosis of the dumping syndrome. Changes in plasma volume and blood sugar after a test meal. Acta Med. Scand. 188, 479–486 (1970).

    Article  CAS  PubMed  Google Scholar 

  13. van der Kleij, F. G., Vecht, J., Lamers, C. B. & Masclee, A. A. Diagnostic value of dumping provocation in patients after gastric surgery. Scand. J. Gastroenterol. 31, 1162–1166 (1996).

    Article  CAS  PubMed  Google Scholar 

  14. Arts, J. et al. Efficacy of the long-acting repeatable formulation of the somatostatin analog octreotide in postoperative dumping. Clin. Gastroenterol. Hepatol. 7, 432–437 (2009).

    Article  CAS  PubMed  Google Scholar 

  15. Lawaetz, O. et al. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scand. J. Gastoenterol. 18, 73–80 (1983).

    Article  CAS  Google Scholar 

  16. Johnson, L. P., Sloop, R. D. & Jesseph, R. E. Etiologic significance of the early symptomatic phase in the dumping syndrome. Ann. Surg. 156, 173–179 (1962).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Sirinek, K. R., O'Dorisio, T. M., Howe, B. & McFee, A. S. Neurotensin, vasoactive intestinal peptide, and Roux-en-Y gastrojejunostomy: their role in the dumping syndrome. Arch. Surg. 120, 605–609 (1985).

    Article  CAS  PubMed  Google Scholar 

  18. Eloy, R., Garaud, J. C., Moody, A., Jaeck, D. & Grenier, J. F. Jejunal factor stimulating insulin release in the isolated perfused canine pancreas and jejunum. Horm. Metab. Res. 7, 461–467 (1975).

    Article  CAS  PubMed  Google Scholar 

  19. Toft-Nielsen, M., Madsbad, S. & Holst, J. J. Exaggerated secretion of glucagon-like peptide-1 could cause reactive hypoglycemia. Diabetologia 41, 1180–1186 (1998).

    Article  CAS  PubMed  Google Scholar 

  20. Service, G. J. et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N. Engl. J. Med. 353, 249–254 (2005).

    Article  CAS  PubMed  Google Scholar 

  21. Patti, M. E. et al. Severe hypoglycemia post-gastric bypass requiring partial pncreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48, 2236–2240 (2005).

    Article  CAS  PubMed  Google Scholar 

  22. Meier, J. J., Butler, A. E., Galasso, R. & Butler, P. C. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 49, 1554–1559 (2006).

    Article  Google Scholar 

  23. Robinson, F. W. & Pittman, A. C. Dietary management of postgastrectomy dumping syndrome. Surg. Gynecol. Obstet. 104, 529–534 (1957).

    CAS  PubMed  Google Scholar 

  24. Pittman, A. C. & Robinson, F. W. Dietary management of the “dumping” syndrome: long-term follow-up. J. Am. Diet. Assoc. 40, 108–110 (1962).

    CAS  PubMed  Google Scholar 

  25. Khoshoo, V., Reifen, R. M., Gold, B. D., Sherman, P. M. & Pencharz, P. B. Nutritional manipulation in the management of dumping syndrome. Arch. Dis. Child 66, 1447–1448 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Harju, E. & Larmi, T. K. Efficacy of guar gum in preventing the dumping syndrome. JPEN 7, 470–472 (1983).

    Article  CAS  Google Scholar 

  27. Harju, E., Heikkila, J. & Larmi, T. K. Effect of guar gum on gastric emptying after gastric resection. JPEN 8, 18–20 (1984).

    Article  CAS  Google Scholar 

  28. Harju, E. & Makela, J. Reduction in symptoms after proximal selective vagotomy through increased dietary viscosity. Am. J. Gastroenterol. 79, 861–863 (1984).

    CAS  PubMed  Google Scholar 

  29. Andersen, J. R., Holtug, K. & Uhrenholt, A. Trial of pectin-enriched muffins in patients with severe dumping syndrome after gastric resection: observations on symptoms and gastric emptying pattern. Acta Chir. Scand. 155, 39–41 (1989).

    Article  CAS  PubMed  Google Scholar 

  30. Jenkins, D. J. et al. Effect of dietary fiber on complications of gastric surgery: prevention of postprandial hypoglycemia by pectin. Gastroenterology 73, 215–217 (1977).

    Article  CAS  PubMed  Google Scholar 

  31. Leeds, A. R., Ralphs, D. N., Ebied, F., Metz, G. & Dilawari, J. B. Pectin in the dumping syndrome: reduction of symptoms and plasma volume changes. Lancet 1, 1075–1078 (1981).

    Article  CAS  PubMed  Google Scholar 

  32. Lawaetz, O., Blackburn, A. M., Bloom, S. R., Aritas, Y. & Raplhs, D. N. Effect of pectin on gastric emptying and gut hormone release in the dumping syndrome. Scand. J. Gastroenterol. 18, 327–336 (1983).

    Article  CAS  PubMed  Google Scholar 

  33. Lyons, T. J., McLoughlin, J. C., Shaw, C. & Buchanan, K. D. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion 31, 89–96 (1985).

    Article  CAS  PubMed  Google Scholar 

  34. Hasegawa, T. et al. Long-term effect of α-glycosidase inhibitor on late dumping syndrome. J. Gastroenterol. Hepatol. 13, 1201–1206 (1998).

    CAS  PubMed  Google Scholar 

  35. Gerard, J., Luyckx, A. S. & Lefebvre, P. J. Acarbose in reactive hypoglycemia: a double-blind study. Int. J. Clin. Pharmacol. Ther. Toxicol. 22, 25–31 (1983).

    Google Scholar 

  36. McLoughlin, J. C., Buchanan, K. D. & Alam, M. J. α-Glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet 2, 603–605 (1979).

    Article  CAS  PubMed  Google Scholar 

  37. Ng, D. D. et al. Acarbose treatment of postprandial hypglycemia in children after Nissen fundoplication. J. Pediatr. 139, 877–879 (2001).

    Article  CAS  PubMed  Google Scholar 

  38. Moreira, R. O., Moreira, R. B., Machado, N. A., Goncalves, T. B. & Coutinho, W. F. Postprandial hypoglycemia after bariatric surgery pharmacological treatment with verapamil and acarbose. Obes. Surg. 18, 1618–1621 (2008).

    Article  PubMed  Google Scholar 

  39. Edmunds, M., Chen, J., Soykan, I., Lin, Z. & McCallum, W. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment. Pharmacol. Ther. 12, 167–174 (1998).

    Article  CAS  PubMed  Google Scholar 

  40. Fuessl, H., Carolan, G., Williams, G. & Bloom, S. Effect of a long-acting somatostatin analog (SMS 201–995) on postprandial gastric emptying of 99mTc–tin colloid and mouth-to-caecum transit time in man. Digestion 36, 101–107 (1987).

    Article  CAS  PubMed  Google Scholar 

  41. van Berge Henegouwen, M. I., van Gulik, T. M., Akkermans, L. M., Jansen, J. B. & Gouma, D. J. The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers. Gut 41, 758–762 (1997).

    Article  CAS  PubMed  Google Scholar 

  42. Foxx-Orenstein, A., Camilleri, M., Stephens, D. & Burton, D. Effect of a somatostatin analog on gastric motor and sensory functions in healthy humans. Gut 52, 1555–1561 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Di Lorenzo, C., Lucanto, C., Flores, A., Idries, S. & Hyman, P. Effect of sequential erythromycin and octreotide on antroduodenal manometry. J. Pediatr. Gastroenterol. Nutr. 29, 293–296 (1999).

    Article  CAS  PubMed  Google Scholar 

  44. Nelson-Piercy, C. et al. Effect of a new oral somatostatin analog (SDZCO611) on gastric emptying, mouth to cecum transit time, and pancreatic and gut hormone release in normal male subjects. J. Clin. Endocrinol. Metab. 78, 329–336 (1994).

    CAS  PubMed  Google Scholar 

  45. von der Ohe, M., Camilleri, M., Thomforde, G. & Klee, G. Differential regional effects of octreotide on human gastrointestinal motor function. Gut 36, 743–748 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Kreanzlin, M. et al. Effect of long-acting somatostatin analog SMS 201–995 on gut hormone secretion in normal subjects. Experintia 41, 738–740 (1985).

    Article  Google Scholar 

  47. Williams, G. et al. Postprandial effects of SMS 201–995 on gut hormones and glucose tolerance. Scand. J. Gastroenterol. 21 (Suppl. 119), 73–83 (1986).

    Article  Google Scholar 

  48. Parkinson, C. et al. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. J. Clin. Endocrinol. Metab. 87, 1797–1804 (2002).

    Article  CAS  PubMed  Google Scholar 

  49. Kemmer, T. P. et al. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analog octreotide (SMS201–995). Aliment. Pharmacol. Ther. 6, 41–50 (1992).

    Article  CAS  PubMed  Google Scholar 

  50. Högenauer, C., Aichbichler, B., Santa Ana, C., Porter, J. & Fordtran, J. Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo. Aliment. Pharmacol. Ther. 16, 769–777 (2002).

    Article  PubMed  Google Scholar 

  51. Hopman, W., Wolberink, R., Lamers, C. & Van Tongeren, J. Treatment of the dumping syndrome with the somatostatin analog SMS201–995. Ann. Surg. 207, 155–159 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Primrose, J. N. & Johnston, D. Somatostatin analog SMS 201–995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br. J. Surg. 76, 140–144 (1989).

    Article  CAS  PubMed  Google Scholar 

  53. Morz, R., Prager, J. & Pointer, H. Influence of somatostatin (SS-14) on early dumping reaction in patients after partial gastrectomy [German]. Z. Gastroenterol. 20, 299–304 (1982).

    CAS  PubMed  Google Scholar 

  54. Long, R., Adrian, T. & Bloom, S. Somatostatin and the dumping syndrome. Br. Med. J. (Clin. Res.) 290, 886–888 (1985).

    Article  CAS  Google Scholar 

  55. Reasbeck, P. & Van Rij, A. The effect of somatostatin on dumping after gastric surgery: a preliminary report. Surgery 99, 462–468 (1986).

    CAS  PubMed  Google Scholar 

  56. Tulassay, Z., Tulassay, T., Gupta, R. & Cierny, G. Long acting somatostatin analog in dumping syndrome. Br. J. Surg. 76, 1294–1295 (1989).

    Article  CAS  PubMed  Google Scholar 

  57. Geer, R. J. et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann. Surg. 212, 678–687 (1990).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Richards, W. O. et al. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J. Surg. Res. 49, 483–487 (1990).

    Article  CAS  PubMed  Google Scholar 

  59. Gray, J. L., Debas, H. T. & Mulvihill, S. J. Control of dumping symptoms by somatostatin analog in patients after gastric surgery. Arch. Surg. 126, 1231–1235 (1991).

    Article  CAS  PubMed  Google Scholar 

  60. Hasler, W. L., Soudah, H. C. & Owyang, C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J. Pharmacol. Exp. Ther. 277, 1359–1365 (1996).

    CAS  PubMed  Google Scholar 

  61. Vecht, J., Lamers, C. & Masclee, A. Long-term results of octreotide-therapy in severe dumping syndrome. Clin. Endocrinol. (Oxf.) 51, 619–624 (1999).

    Article  CAS  Google Scholar 

  62. Didden, P., Penning, C. & Masclee, A. A. Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment. Pharmacol. Ther. 24, 1367–1375 (2006).

    Article  CAS  PubMed  Google Scholar 

  63. Penning, C., Vecht, J. & Masclee, A. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Aliment. Pharmacol. Ther. 22, 963–969 (2005).

    Article  CAS  PubMed  Google Scholar 

  64. Ewins, D. L. et al. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q. J. Med. 83, 295–306 (1992).

    CAS  PubMed  Google Scholar 

  65. Moschetta, A. et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment. Pharmacol. Ther. 15, 181–185 (2001).

    Article  CAS  PubMed  Google Scholar 

  66. Woodward, E. R., Deser, P. L. & Gasster, M. Surgical treatment of the postgastrectomy dumping syndrome. West. J. Surg. Obstet. Gynecol. 63, 567–573 (1955).

    CAS  PubMed  Google Scholar 

  67. Sawyers, J. L. & Herrington, J. L. Superiority of antipersitaltic jejunal segments in management of severe dumping syndrome. Ann. Surg. 178, 311–321 (1973).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Koruth, N. M., Krukowski, Z. H. & Matheson, N. A. Pyloric reconstruction. Br. J. Surg. 72, 808–810 (1985).

    Article  CAS  PubMed  Google Scholar 

  69. Cheadle, W. G., Baker, P. R. & Cuschieri, A. Pyloric reconstruction for severe vasomotor dumping after vagotomy and pylorpoplasty. Ann. Surg. 202, 568–572 (1985).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Vogel, S., Hocking, M. & Woodward, E. Clinical and radionuclide evaluation of Roux-Y diversion for postgastrectomy dumping. Am. J. Surg. 155, 57–62 (1988).

    Article  CAS  PubMed  Google Scholar 

  71. Hocking, M. P., Vogel, S. B., Falasca, C. A. & Woodward, E. R. Delayed gastric emptying of liquids and solids following Roux-en-Y biliary diversion. Ann. Surg. 194, 494–501 (1981).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Ramus, N., Williamson, R. & Jonhston, D. The use of jejunal interposition for intractable symptoms complicating peptic ulcer surgery. Br. J. Surg. 69, 265–268 (1982).

    Article  CAS  PubMed  Google Scholar 

  73. Veit, F., Heine, R. G. & Catto-Smith, A. G. Dumping syndrome after Nissen fundoplication. J. Pediatr. Child Health 30, 182–185 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Désirée Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan Tack.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tack, J., Arts, J., Caenepeel, P. et al. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 6, 583–590 (2009). https://doi.org/10.1038/nrgastro.2009.148

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2009.148

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing